Related Experiment Video
Updated: Oct 6, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Validation of Heart Failure-Specific Risk Equations in 1.3 Million Israeli Adults and Usefulness of Combining
Sadiya S Khan1, Noam Barda2, Philip Greenland3
1Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Insights
Heart failure risk prediction equations accurately identify at-risk individuals. The Pooled Cohort Equations to Prevent Heart Failure (PCP-HF) model shows strong performance in a large, real-world Israeli dataset, aiding in global HF prevention efforts.
Area of Science:
- Cardiology
- Public Health
- Epidemiology
Background:
- Rising global heart failure (HF) prevalence necessitates effective prevention strategies.
- Current HF risk prediction models often lack validation in diverse, real-world populations outside the US.
- Accurate risk assessment is crucial for targeted HF prevention interventions.
Purpose of the Study:
- To externally validate the performance of the Pooled Cohort Equations to Prevent Heart Failure (PCP-HF) for 5- and 10-year risk prediction.
- To assess the PCP-HF model's accuracy in a large, contemporary Israeli cohort using electronic health records.
- To evaluate the utility of these equations for predicting incident HF in a non-US population.
Main Methods:
- Retrospective cohort study of 1,394,411 Israeli residents (2008-2018).
- Utilized electronic health records to extract demographics and risk factors (BMI, BP, glucose, medications, smoking).
- Applied PCP-HF equations to estimate 5- and 10-year HF risk and assessed model discrimination (C-statistic).
Main Results:
- The PCP-HF model demonstrated excellent discrimination for 5-year (C-statistic=0.82) and 10-year (C-statistic=0.84) incident HF prediction.
- Incident HF occurred in 1.2% of participants over 5 years and 4.5% over 10 years.
- The model performed well across a large, diverse patient population.
Conclusions:
- The PCP-HF risk prediction equations are accurate and reliable for estimating 5- and 10-year HF risk in a non-US population.
- These validated equations can be effectively used with routinely collected clinical data for HF risk stratification.
- The findings support the broader application of PCP-HF for global heart failure prevention efforts.
Abstract:
Heart failure (HF) prevalence is increasing worldwide and is associated with significant morbidity and mortality. Guidelines emphasize prevention in those at-risk, but HF-specific risk prediction equations developed in United States population-based cohorts lack external validation in large, real-world datasets outside of the United States. The purpose of this study was to assess the model performance of the pooled cohort equations to prevent HF (PCP-HF) within a contemporary electronic health record for 5- and 10-year risk. Using a retrospective cohort study design of Israeli residents between 2008 and 2018 with continuous membership until end of follow-up, HF, or death, we quantified 5- and 10-year estimated risks of HF using the PCP-HF equations, which integrate demographics (age, gender, and race) and risk factors (body mass index, systolic blood pressure, glucose, medication use for hypertension or diabetes, and smoking status). Of 1,394,411 patients included, 56% were women with mean age of 49.6 (SD 13.2) years. Incident HF occurred in 1.2% and 4.5% of participants over 5 and 10 years of follow-up. The PCP-HF model had excellent discrimination for 5- and 10-year predictions of incident HF (C Statistic 0.82 [0.82 to 0.82] and 0.84 [0.84 to 0.84]), respectively. In conclusion, HF-specific risk equations (PCP-HF) accurately predict the risk of incident HF in ambulatory and hospitalized patients using routinely available clinical data.
More Related Videos
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure III: Clinical Manifestations
Heart Failure V: Medical Management

